Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
87,42 EUR | -0,66% | -1,05% | -2,62% |
18/03 | AstraZeneca volgt rivaal Boehringer in het aftoppen van out-of-pocket kosten voor inhalatoren | RE |
14/03 | Sanofi werkt samen met AI-gestuurde Drug Assets Manager Partex | MT |
Omzet 2024 * | 46,45 mld. 50,39 mld. | Omzet 2025 * | 50,24 mld. 54,5 mld. | Marktkapitalisatie | 110 mld. 119 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,34 mld. 7,97 mld. | Nettowinst (verlies) 2025 * | 8,68 mld. 9,42 mld. | EV/omzet 2024 * | 2,52 x |
Nettoschuld 2024 * | 6,96 mld. 7,55 mld. | Nettoschuld 2025 * | 2,42 mld. 2,63 mld. | EV/omzet 2025 * | 2,24 x |
K/w-verhouding 2024 * |
14,6
x | K/w-verhouding 2025 * |
12,4
x | Werknemers | 86.088 |
Dividendrendement 2024 * |
4,36% | Dividendrendement 2025 * |
4,73% | Vrij verhandelbaar | 87,77% |
Recentste transcriptie over Sanofi
1 dag | -0,67% | ||
1 week | -1,05% | ||
Lopende maand | -0,55% | ||
1 maand | +1,38% | ||
3 maanden | -1,71% | ||
6 maanden | -14,39% | ||
Lopend jaar | -2,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 01-09-19 |
Director of Finance/CFO | 59 | 01-10-18 | |
Nestle Frank
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 01-05-14 |
Lise Kingo
BRD | Director/Board Member | 62 | 28-04-20 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 22-05-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
6.31% | 5 M€ | +4,56% | ||
3.66% | 129 M€ | -.--% | - | |
3.55% | 264 M€ | +13,50% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-03-24 | 87,42 | -0,66% | 84 018 |
18-03-24 | 88 | -0,23% | 813 952 |
15-03-24 | 88,2 | -0,01% | 3 106 988 |
14-03-24 | 88,21 | -0,32% | 1 249 466 |
13-03-24 | 88,49 | +0,17% | 1 017 214 |
Real Time Euronext Paris, 19 maart 2024 om 10:19 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,62% | 119 mld. | |
+30,83% | 687 mld. | |
+30,91% | 595 mld. | |
+0,01% | 378 mld. | |
+15,18% | 316 mld. | |
+11,39% | 308 mld. | |
+0,34% | 211 mld. | |
-6,28% | 208 mld. | |
-3,79% | 203 mld. | |
-3,72% | 157 mld. |